India’s Advinus Signs On With Genzyme In Malaria Research
Development of malaria drugs could qualify Genzyme for a priority review voucher under FDA’s tropical disease incentive.
Development of malaria drugs could qualify Genzyme for a priority review voucher under FDA’s tropical disease incentive.